Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma 论文

2013Journal of Clinical Oncology引用 363
DOIPDF
Melanoma and MAPK PathwaysComputational Drug Discovery MethodsCytokine Signaling Pathways and Interactions
Computational Drug Discovery MethodsMelanoma and MAPK PathwaysCytokine Signaling Pathways and Interactions
相关技术:Computational Drug Discovery Methods
关系图谱

Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma · 作者

A

Antoni Ribas

J

Jeffrey A. Sosman

A

Andrew K. Joe

R

Richard J. Lee

G

Gideon Bollag

L

Louise Cockey

H

Houston Gilbert

A

Annette Schell-Steven

O

Olivia Spleiss

M

Mark Kockx

A

Astrid Koehler

R

Roger S. Lo

I

Igor Puzanov

K

Karl D. Lewis

R

Ravi K. Amaravadi

P

Patrick A. Ott

D

Donald P. Lawrence

G

Georgina V. Long

P

Peter Hersey

J

Jeffrey S. Weber

K

Kevin B. Kim

K

Keith T. Flaherty

S

Stergios J. Moschos

T

Thomas E. Hutson

G

Grant A. McArthur

R

René González

L

Lynn M. Schuchter

A

Anna C. Pavlick

K

Kerstin Trunzer